University of Dundee Commercialisation Strategies

1
University of Dundee Commercialisation Strategies

• James Houston
• Director
• Research and Innovation Services

Research Innovation Services
2
Balancing
Risk against Opportunity
3

• IPR
• Protection
• Marketing
• Licence
• Company creation

• Publications
• Academic freedom
• Research assessment

Academic community

• Funding
• Industry
• Charities
• Research Councils
• E.U.

• Contract
• Studentship
• Collaborative
• Licence
• Articles Mem

4
Research Awards 2001/2002 56m

• Made up of
• Charities 27m
• Research Councils 16m
• Collaborative Research 6m
• Industry 7m

5
University of DundeeCommercialisation Indicators
2001/2002
Research Awards 56m No of Disclosures
35 No of Patents filed 29 Licences
granted 10 Spin outs formed
4 Licensing income 1.4m
6
Current Commercialisation Portfolio

• Families of Patents
• and Applications 100
• Licence Agreements 40
• Spin out Companies 12

7
Drivers of Commercialisation

• Central Government Knowledge - Based Economy
• University Challenge Fund
• Science Enterprise Challenge Centre for
  Enterprise Management
• SHEFC Knowledge Transfer Grant
• Local Economic Development
• Support from SET
• Sponsor Obligations
• Research Councils - maximise publications and
  maximise commercial return
• Charities
• Industry driven by the commercial imperative

8
University Commercialisation StrategyKey
commercialisation routes

• Research Consortia
• Licence Agreements
• Company Creation

9
Research Consortium 1

• University of Dundee and 15 major
• Pharma companies
• 30/70 DTI LINK / industry funding

10
Research Consortium 1
Outcomes

• Successful 5 year programme
• 3 new consortia formed
• additional studentships and research
  collaborations funded
• 2 spin out companies Cypex and CXR Biosciences
  formed

11
Research Consortium 2

• Focused signal transduction RD Centre
• 5 major pharmaceutical partners
• gt8m/(12m) investment over 5 years
• Second round funding gt 15m (22m)

12
Research Consortium 2
Outcomes

• Successful two way Technology Transfer
• Additional research collaborations funded
• Licensing deals secured
• Inward investment of US company Upstate
• Phase II of the development started 1 June 2003

13
Spin out companies

• Axis-Shield Ltd - in vitro Diagnostics Company
• spin out from University in 1982
• Largest Biotech. Company in Scotland
• Cyclacel - Drug Discovery Company
• founded on IPR developed at the University of
  Dundee by
• Sir David Lane
• Cypex - Reagents Company
• founded from IP arising from Prof Roland Wolf
  Prof Brian Burchell LINK program 8 years ago
• CXR Biosciences Drug discovery development and
  investigative toxicology company
• Founded by Prof R wolf and Dr C Elcombe

CXR Biosciences
14
Spin -out Proposal
IPR Commercial Due Diligence Commissioned
Market Analysis
RIS and/or External Advisors
NO
Licence
YES
Proposal Presented to Business Ventures Group
RIS
NO
Licence or Re-Work Proposal or Pre-Incubation
YES
Equity Split Agreed University/Academic
Innovator
RIS
15
Company Incorporation
RIS
Business Plan Development
RIS and/or External Advisors
Transfer of IPR
RIS
Accommodation/ Incubator Facilities
RIS/SET/ Stakeholders
16
Funding for the Commercialisation of Biosciences
at the University of Dundee

• Innovation
• Proof of Concept Fund
• Business Ventures Fund
• NESTech Seed Fund
• Company Formation
• Angel/ V.C. Funding

Local Enterprise Company Support
Royal Society Fellowships
Central Govt. Initiatives
17
NESTech- North East of Scotland Technology Fund

• A new 3m (4.5m) Seed Fund
• for the Universities of
• Dundee
• Aberdeen
• St Andrews

18
NESTech

• Created through a successful application from
  theTechnology Transfer Offices to the Office of
  Science and Technology University Challenge Fund
• With additional financial support from
• Tayside, Grampian and Fife Local Enterprise
  Companies

19
NESTech

• Grants of lt30k for-
• Business Plans
• Market Research
• Proof of principle studies
• Patent costs
• Prototyping

20
NESTech

• Loans/Equity deals 30k-250k
• Technology development
• Company creation

21
Summary

• The Univerity of Dundee is an international
  player in Biosciences research and in the field
  of technology transfer
• The University has adopted a balanced approach to
  commercialisation which includes
• Research Consortia, Licensing and Company
  Creation

22
Summary

• A suite of funding mechanisms has been created to
  support technology development and company
  formation
• RIS supports commercialisation within an
  entrepreneurial culture which has been endorsed
  by the University

23
80 LUCK20 DESIGN